BXN 14.3% 0.8¢ bioxyne limited

BXN outperforming health supplements sector

  1. 1,573 Posts.
    lightbulb Created with Sketch. 190





    When your guts have gone nuts, who do you call? These ASX stocks are fighting gastrointestinal disease
    Health & Biotech

    February 5, 2020 | Nick Sundich























    Supplements

    Then there are the players that want to keep a healthy gut in tip top shape.
    These include Bioxyne (ASX:BXN) which makes infant formula supplements. Despite not being a pure infant formula play it outperformed them all last month, gaining 21 per cent.
    Another player is Probiotec (ASXBP), which among other things makes diet shakes and offers customised weight loss programs.
    Also selling gut-friendly foods are Holista CollTech (ASX:HCT) and Eagle Health (ASX:EHH).



    Can't paste the link, stock head article. To read all google the headline.
    Last edited by zx65: 04/03/20
 
watchlist Created with Sketch. Add BXN (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
0.001(14.3%)
Mkt cap ! $16.37M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $2.512K 313.9K

Buyers (Bids)

No. Vol. Price($)
5 1225424 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.8¢ 1652174 3
View Market Depth
Last trade - 15.56pm 26/04/2024 (20 minute delay) ?
BXN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.